Kanishk Kharbanda Appointed As Director Of International Business
ncarol.com/10122157

MORRISVILLE, N.C. - ncarol.com -- BioMedomics, Inc. has announced that Mr. Kanishk Kharbanda has been appointed as Director of International Business with immediate effect. In his new role, Mr. Kharbanda will be responsible for the success of all outside-US operations which include sales, marketing, regulatory, logistics and manufacturing strategy. He will also be responsible for driving sales in Asia Pacific and EU regions.

With over 17 years' experience in international healthcare business, Kanishk has proven himself a visionary leader, strategic thinker, with a stellar reputation in the industry. Prior to joining BioMedomics Kanishk worked in business strategy consulting, market access, and public health program management in top companies and non-profit foundations. Kanishk earned his Master's in Business degree from the renowned Duke University's Fuqua School of Business and Bachelor's in Engineering degree from Manipal Institute of Technology.

More on ncarol.com

• Husband-and-Wife Photography Team Brings Personal Approach to Families Across the Triangle
• SRK Collective Media Group Launches with a Modern Approach to Media, Authority Building, and Cultural Visibility
• MSBG Corporation Acquires GridWatch US Telemetry Automation System
• TAYP Expands Athlete Exposure Platform Beyond Georgia With New Push Into Virginia and the 757
• KT Medical Staffing Expands Concierge Nursing and Private Duty Nursing Services in Orange County

"We are extremely fortunate and honored to have Kanishk as part of our Leadership Team", said Brad Heidinger, COO of BioMedomics. "Kanishk has been a great asset to our company in his previous role and I know he will continue to be impactful as our Director of International Business. He has an unquestionable skill set and is a real leader that brings both innovation and expertise.  He adds tremendous depth and value to our company."

"With our rich product pipeline and growing international customer base, we're at an inflection point as a company." said Kharbanda. "This brings ample challenges and opportunities - to grow and to streamline in lock step while delivering best-in-class customer experiences. A balancing act we're going to take head on."

For more information about BioMedomics, visit http://www.biomedomics.com